Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA)

Clinical and biological manifestations have been studied in 134 patients whose serum had antibodies to soluble extractable nuclear antigens (ENA). 85 of the patients had anti-RNP antibodies, 18 had anti-Sm antibodies, and 31 had antibodies to one or more soluble nuclear antigen. In all groups, the p...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the rheumatic diseases 1978-08, Vol.37 (4), p.321-327
Main Authors: Gaudreau, A, Amor, B, Kahn, M F, Ryckewaert, A, Sany, J, Peltier, A P
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Antibodies, Antinuclear - analysis
Antibody Specificity
Child
Collagen Diseases - immunology
DNA - immunology
Female
Humans
Kidney Diseases - immunology
Male
Middle Aged
Raynaud Disease - immunology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Clinical and biological manifestations have been studied in 134 patients whose serum had antibodies to soluble extractable nuclear antigens (ENA). 85 of the patients had anti-RNP antibodies, 18 had anti-Sm antibodies, and 31 had antibodies to one or more soluble nuclear antigen. In all groups, the predominant clinical manifestations were polyarthritis, Raynaud's phenomenon, fever, and skin involvement. Renal disease was less common in those patients with anti-RNP antibodies than in the other patients. Most patients with definite renal disease (13 out of 15) also had circulating anti-DNA antibodies. The final diagnoses in these 134 patients were well defined connective tissue disease in 59; overlap syndromes in 34; a limited clinical syndrome made up of polyarthritis Raynaud's phenomenon--often with swollen fingers--and/or hypergammaglobulin-aemia in 31, and various other clinical conditions in 10.
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.37.4.321